Navigating Eosinophilic Esophagitis Care from Recognition to Long-Term Management - Episode 9
Defining Treatment Success and Disease Control in EoE Care
Feeling better does not always mean EoE is fully controlled. The panel explores how patient goals, symptoms, endoscopic findings, and histology come together to provide a more complete picture of treatment success.
In ‘Defining Treatment Success and Disease Control in EoE Care,’ our panel explores how clinicians and patients can establish meaningful treatment goals and assess disease control following initial therapy for eosinophilic esophagitis. The expert faculty emphasize that successful treatment requires balancing outcomes that matter most to patients with objective measures of disease activity.
The panelists discuss the importance of first understanding what improvement means to an individual patient. For some, success may mean eating without food sticking, eliminating the need for liquid chasers, or feeling comfortable dining in social settings. Because patients may have lived with EoE symptoms for years, the panel highlights how adaptive eating behaviors can become normalized and persist even after disease control improves. Establishing patient-defined goals early can therefore help clinicians better understand changes in symptoms and quality of life throughout treatment.
The expert faculty also explain why symptom improvement represents only one component of treatment success. Endoscopic improvement and histologic response provide important objective measures of disease activity, particularly because symptoms, endoscopic findings, and histology may not always align. The panel discusses incorporating these complementary measures when determining whether a patient has achieved meaningful disease control after an initial treatment course.
Throughout the episode, the panel emphasizes partnership between clinicians and patients when establishing expectations for treatment. By aligning patient priorities with clinical goals and explaining the need for continued objective assessment, clinicians can help patients understand why feeling better does not necessarily indicate complete disease control. This multidimensional approach provides a more comprehensive picture of treatment response and can help guide the next phase of EoE management.
Our next episode, ‘Monitoring Disease Control in EoE,’ examines how symptoms, patient behaviors, endoscopic findings, and histology can be integrated to monitor patients established on therapy. The panelists also discuss how individual disease history, treatment adherence, and changes in clinical status can guide the timing of reassessment.
